For the particular case of malaria, small molecules acting with biologically relevant affinity on multiple P. falciparum targets represent an interesting strategy to retain therapeutic efficacy against the potential emergence of parasite resistance on individual targets, a concept already proposed for antimalarial protein kinase inhibitors [33], [34]. This evidence concerns the gene WEE1 and malaria.